Hypoxia-inducible factor 1a is a Tsc1-regulated survival factor in newborn neurons in tuberous sclerosis complex

Human Molecular Genetics

Volumn 22, Issue 9, 2013, Pages 1725-1734

  Feliciano, David M ^a   Zhang, Shiliang ^a   Quon, Jennifer L ^a   Bordey, Angélique ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; ECHINOMYCIN; ENHANCED GREEN FLUORESCENT PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; SHORT HAIRPIN RNA;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ELECTROPORATION; GENE MUTATION; GENETIC TRANSCRIPTION; GENOTYPE; GRANULE CELL; HEMISPHERE; IMMUNOHISTOCHEMISTRY; LATERAL BRAIN VENTRICLE; MOUSE; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NEUROBLAST; NEUROBLASTOMA CELL; NEWBORN; NONHUMAN; NULL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA ISOLATION; STEM CELL; SUBVENTRICULAR ZONE; SURVIVAL FACTOR; SYNAPSE; TRANSACTIVATION; TUBEROUS SCLEROSIS;

ANIMALS; FEMALE; GENOTYPE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; MICE, TRANSGENIC; NEURONS; RNA, SMALL INTERFERING; STEM CELLS; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

MAMMALIA; MUS;

EID: 84875927231     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt018     Document Type: Article

References (50)

1. Cheadle, J.P., Reeve, M.P., Sampson, J.R. and Kwiatkowski, D.J. (2000) Molecular genetic advances in tuberous sclerosis. Hum. Genet., 107, 97-114.
2. Crino, P.B., Nathanson, K.L. and Henske, E.P. (2006) The tuberous sclerosis complex. N. Engl. J. Med., 355, 1345-1356.
3. Curatolo, P., Bombardieri, R. and Jozwiak, S. (2008) Tuberous sclerosis. Lancet, 372, 657-668.
4. Tsai, P. and Sahin, M. (2011) Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex. Curr. Opin. Neurol., 24, 106-113.
5. Ehninger, D., de Vries, P.J. and Silva, A.J. (2009) From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis. J Intellect. Disabil. Res., 53, 838-851.
6. Miyata, H., Chiang, A.C. and Vinters, H.V. (2004) Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Ann. Neurol., 56, 510-519.
7. Baybis, M., Yu, J., Lee, A., Golden, J.A., Weiner, H., McKhann, G., Aronica, E. and Crino, P.B. (2004) mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann. Neurol., 56, 478-487.
8. Parker, W.E., Orlova, K.A., Heuer, G.G., Baybis, M., Aronica, E., Frost, M., Wong, M. and Crino, P.B. (2011) Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex. Am. J. Pathol., 178, 296-305.
9. Wang, G.L. and Semenza, G.L. (1993) Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol. Chem., 268, 21513-21518.
10. Wang, G.L. and Semenza, G.L. (1993) General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA, 90, 4304-4308.
11. Semenza, G.L. (2012) Hypoxia-inducible factors in physiology and medicine. Cell, 148, 399-408.
12. Chen, B. and Cepko, C.L. (2009) HDAC4 regulates neuronal survival in normal and diseased retinas. Science, 323, 256-259.
13. Mazumdar, J., O'Brien, W.T., Johnson, R.S., Lamanna, J.C., Chavez, J.C., Klein, P.S. and Simon, M.C. (2010) O2 regulates stem cells through Wnt/beta-catenin signalling. Nat. Cell Biol., 12, 1007-1013.
14. El-Hashemite, N., Walker, V., Zhang, H. and Kwiatkowski, D.J. (2003) Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin. Cancer Res., 63, 5173-5177.
15. Liu, M.Y., Poellinger, L. and Walker, C.L. (2003) Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene. Cancer Res., 63, 2675-2680.
16. Brugarolas, J. and Kaelin, W.G. Jr. (2004) Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes. Cancer Cell, 6, 7-10.
17. Shackelford, D.B., Vasquez, D.S., Corbeil, J., Wu, S., Leblanc, M., Wu, C.L., Vera, D.R. and Shaw, R.J. (2009) mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome. Proc. Natl. Acad. Sci. USA, 106, 11137-11142.
18. Choo, A.Y., Kim, S.G., Vander Heiden, M.G., Mahoney, S.J., Vu, H., Yoon, S.O., Cantley, L.C. and Blenis, J. (2010) Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. Mol. Cell, 38, 487-499.
19. Brugarolas, J.B., Vazquez, F., Reddy, A., Sellers, W.R. and Kaelin, W.G. Jr. (2003) TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell, 4, 147-158.
20. Duvel, K., Yecies, J.L., Menon, S., Raman, P., Lipovsky, A.I., Souza, A.L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S. et al. (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell, 39, 171-183.
21. Bhaskar, P.T., Nogueira, V., Patra, K.C., Jeon, S.M., Park, Y., Robey, R.B. and Hay, N. (2009) mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition. Mol. Cell Biol., 29, 5136-5147.
22. Feliciano, D.M., Quon, J.L., Su, T., Taylor, M.M. and Bordey, A. (2012) Postnatal neurogenesis generates heterotopias, olfactory micronodules and cortical infiltration following single-cell Tsc1 deletion. Hum. Mol. Genet., 21, 799-810.
23. Platel, J.C., Dave, K.A., Gordon, V., Lacar, B., Rubio, M.E. and Bordey, A. (2010) NMDA receptors activated by subventricular zone astrocytic glutamate are critical for neuroblast survival prior to entering a synaptic network. Neuron, 65, 859-872.
24. Lacar, B., Young, S.Z., Platel, J.C. and Bordey, A. (2010) Imaging and recording subventricular zone progenitor cells in live tissue of postnatal mice. Front Neurosci., 4, 43.
25. Lafourcade, C., Lin, T.V., Feliciano, D.M., Zhang, L., Hsieh, L.S., Bordonaro, J. and Bordey, A. (2012) Rheb activation in SVZ progenitors leads to heterotopia, ectopic neuronal differentiation, and rapamycin-sensitive micronodules and dendrite hypertrophy of newborn neurons. J. Neurosci., 33.
26. Pathania, M., Torres-Reveron, J., Yan, L., Kimura, T., Lin, T.V., Gordon, V., Teng, Z.Q., Zhao, X., Fulga, T.A., Van, V.D. and Bordey, A. (2012) miR-132 enhances dendritic morphogenesis, spine density, synaptic integration, and survival of newborn olfactory bulb neurons. PLoS One, 7, e38174.
27. Young, S.Z., Taylor, M.M., Wu, S., Ikeda-Matsuo, Y., Kubera, C. and Bordey, A. (2012) NKCC1 knockdown decreases neuron production through GABAA-regulated neural progenitor proliferation and delays dendrite development. J. Neurosci., 32, 13630-13638.
28. Nakamura, K., Martin, K.C., Jackson, J.K., Beppu, K., Woo, C.W. and Thiele, C.J. (2006) Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells. Cancer Res., 66, 4249-4255.
29. Kong, D., Park, E.J., Stephen, A.G., Calvani, M., Cardellina, J.H., Monks, A., Fisher, R.J., Shoemaker, R.H. and Melillo, G. (2005) Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. Cancer Res., 65, 9047-9055.
30. Wang, Y., Liu, Y., Malek, S.N., Zheng, P. and Liu, Y. (2011) Targeting HIF1alpha eliminates cancer stem cells in hematological malignancies. Cell Stem Cell, 8, 399-411.
31. Ventura, A., Meissner, A., Dillon, C.P., McManus, M., Sharp, P.A., Van Parijs, L., Jaenisch, R. and Jacks, T. (2004) Cre-lox-regulated conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. USA, 101, 10380-10385.
32. Ridler, K., Suckling, J., Higgins, N., Bolton, P. and Bullmore, E. (2004) Standardized whole brain mapping of tubers and subependymal nodules in tuberous sclerosis complex. J. Child Neurol., 19, 658-665.
33. de Leon, G.A., Zaeri, N. and Foley, C.M. (1988) Olfactory hamartomas in tuberous sclerosis. J. Neurol. Sci., 87, 187-194.
34. Meikle, L., Talos, D.M., Onda, H., Pollizzi, K., Rotenberg, A., Sahin, M., Jensen, F.E. and Kwiatkowski, D.J. (2007) A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J. Neurosci., 27, 5546-5558.
35. Goto, J., Talos, D.M., Klein, P., Qin, W., Chekaluk, Y.I., Anderl, S., Malinowska, I.A., Di, N.A., Bronson, R.T., Chan, J.A. et al. (2011) Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proc. Natl. Acad. Sci. USA, 108, E1070-E1079.
36. Zeng, L.H., Rensing, N.R., Zhang, B., Gutmann, D.H., Gambello, M.J. and Wong, M. (2010) Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of Tuberous Sclerosis Complex. Hum. Mol. Genet., 20, 445-454.
37. Way, S.W., McKenna, J. III, Mietzsch, U., Reith, R.M., Wu, H.C. and Gambello, M.J. (2009) Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Hum. Mol. Genet., 18, 1252-1265.
38. Magri, L., Cambiaghi, M., Cominelli, M., Alfaro-Cervello, C., Cursi, M., Pala, M., Bulfone, A., Garcia-Verdugo, J.M., Leocani, L., Minicucci, F. et al. (2011) Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions. Cell Stem Cell, 9, 447-462.
39. Carson, R.P., Van Nielen, D.L., Winzenburger, P.A. and Ess, K.C. (2012) Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin. Neurobiol. Dis., 45, 369-380.
40. Govindarajan, B., Brat, D.J., Csete, M., Martin, W.D., Murad, E., Litani, K., Cohen, C., Cerimele, F., Nunnelley, M., Lefkove, B. et al. (2005) Transgenic expression of dominant negative tuberin through a strong constitutive promoter results in a tissue-specific tuberous sclerosis phenotype in the skin and brain. J. Biol. Chem., 280, 5870-5874.
41. Feliciano, D.M., Su, T., Lopez, J., Platel, J.C. and Bordey, A. (2011) Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice. J. Clin. Invest, 121, 1596-1607.
42. Zhou, J., Shrikhande, G., Xu, J., McKay, R.M., Burns, D.K., Johnson, J.E. and Parada, L.F. (2011) Tsc1 mutant neural stem/progenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle. Genes Dev., 25, 1595-1600.
43. Kim, S.H., Speirs, C.K., Solnica-Krezel, L. and Ess, K.C. (2011) Zebrafish model of tuberous sclerosis complex reveals cell-autonomous and non-cellautonomous functions of mutant tuberin. Dis. Model. Mech., 4, 255-267.
44. Fu, C., Cawthon, B., Clinkscales, W., Bruce, A., Winzenburger, P. and Ess, K.C. (2012) GABAergic interneuron development and function is modulated by the Tsc1 gene. Cereb. Cortex, 22, 2111-2119.
45. Menon, S., Yecies, J.L., Zhang, H.H., Howell, J.J., Nicholatos, J., Harputlugil, E., Bronson, R.T., Kwiatkowski, D.J. and Manning, B.D. (2012) Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. Sci. Signal., 5, ra24.
46. Kucejova, B., Pena-Llopis, S., Yamasaki, T., Sivanand, S., Tran, T.A., Alexander, S., Wolff, N.C., Lotan, Y., Xie, X.J., Kabbani, W. et al. (2011) Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma. Mol. Cancer Res., 9, 1255-1265.
47. Zhang, C.Q., Shu, H.F., Yin, Q., An, N., Xu, S.L., Yin, J.B., Song, Y.C., Liu, S.Y. and Yang, H. (2012) Expression and cellular distribution of vascular endothelial growth factor-C system in cortical tubers of the tuberous sclerosis complex. Brain Pathol., 22, 205-218.
48. Meikle, L., McMullen, J.R., Sherwood, M.C., Lader, A.S., Walker, V., Chan, J.A. and Kwiatkowski, D.J. (2005) A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes. Hum. Mol. Genet., 14, 429-435.
49. Kwiatkowski, D.J., Zhang, H., Bandura, J.L., Heiberger, K.M., Glogauer, M., El-Hashemite, N. and Onda, H. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum. Mol. Genet., 11, 525-534.
50. Platel, J.C., Gordon, V., Heintz, T. and Bordey, A. (2009) GFAP-GFP neural progenitors are antigenically homogeneous and anchored in their enclosed mosaic niche. Glia, 57, 66-78.